Back to Catalog
CREATE Medicines
createmedicines
In vivo CAR T cell therapies using mRNA lipid nanoparticle delivery.
Total Funding
$172M
sector:biotech
stage:series_b
clinical-stage
gene-therapy
oncology
precision-medicine
preclinical
Full Profile Gated
Register as a Qualified Purchaser to access the full profile of CREATE Medicines, including financial analysis, competitive landscape, and investment thesis.